Top Markets
#1 Akedo Akedo +63.33%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.58%
#4 Cross Cross +34.01%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cap Cap +32.66%
#7 Velvet Velvet +25.73%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.06%
#9 Ravencoin Ravencoin +13.84%
#10 DoubleZero DoubleZero +13.55%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Classifica tra le azioni #38911
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Prezzo delle azioni
$0.1645
Capitalizzazione di mercato
$681.26K
Variazione (1 giorno)
-3.69%
Variazione (1 anno)
-95.30%
Paese
US
Scambia Valion Bio, Inc. (VBIO)

Categoria

Healthcare
Storico del prezzo dell'azione per Valion Bio, Inc. (VBIO)
Prezzo di chiusura più alto: $0.24 il 2026-08-01

Prezzo di chiusura più basso: $7.60K il 2021-11-01
Storico del prezzo dell'azione di Valion Bio, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -21.26%
2025 -56.71%
2024 -86.09%
2023 -97.85%
2022 -79.33%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.40 29.49%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $842.41 29.12%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $726.49 6.37%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.46 11.09%
BE